Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories


Clypd attaches itself to AT&T
Tivo and RTL exited television advertising data platform Clypd in an acquisition by AT&T's advertising services subsidiary, Xandr.
TV Time clocks up MediaMorph acquisition
Liberty Global Ventures and Motorola Mobility Ventures both scored exits from the media content monetisation service in an acquisition by TV Time.
Phathom measures out IPO terms
Takeda is set to emerge with almost 26% of Phathom Pharmaceuticals, which has licensed one of its gastrointestinal disease drugs, and which is targeting $158m.
Tela Bio tells of $69m IPO filing
ProMedica and Pacira are both in line for exits after surgical implant producer Tela Bio filed for an initial public offering.
More deals with less capital
Quarterly data report: Q3 2019
Deceleration in September
Monthly analysis: September 2019
The energy sector is still growing
Sector analysis: Energy
Vir Bio rides to $143m in IPO
SoftBank Vision Fund-backed immunology therapy developer Vir will float at the bottom of its range, having raised in excess of $820m in VC funding in roughly three years.

Other News

Fangdd looks to capture $150m in IPO
Online real estate marketplace Fangdd has filed for a $150m initial public offering that would allow Shanying International to exit.
BioNTech binds itself to public markets
The Eli Lilly, Pfizer and Sanofi-backed cancer therapy developer raised $150m despite reducing the number of shares in the IPO and floating beneath its range.
Aprea closes $97.8m IPO
The underwriters for Praktikertjänst-backed Aprea Therapeutics have taken up the over-allotment option in full to boost proceeds to nearly $97.8m.
Honda picks up Drivemode
Panasonic, Mitsui Sumitomo and NEC all booked exits after Honda's R&D unit acquired connected driving assistant technology developer Drivemode.
Group Nine Media sugarcoats PopSugar
Comcast NBCUniversal may have scored an exit at online women's lifestyle brand PopSugar, although the firm was reported to have sold back at least some of its shares in 2009.
ADC abandons IPO plans
The AstraZeneca-backed cancer drug developer had hoped to raise up to $212m in a US flotation but is instead pulling back due to unfavourable market conditions.

Editor's Picks

We Co pulls its IPO - what now?
With news that We Co has withdrawn its IPO filing, we take a look at what the move could mean for corporate venturing going forward.
Peloton pulls itself to billion-dollar IPO
Comcast NBCUniversal and Grace Beauty scored exits as Peloton Interactive floated at the top of its range to raise $1.16bn, getting a further $100m in a private placement.
Cloudflare clocks up $525m in IPO
Alphabet, Baidu, Microsoft and Qualcomm all notched up exits as the cloud services provider floated above a range that had already been increased.
Vertex veers to Semma for $950m acquisition
Novartis, Medtronic and SinoPharm will exit the stem cell-based diabetes therapy developer in an acquisition by Vertex Pharmaceuticals.
test reg